⌘K

Prelude Therapeutics Incorporated (PRLD)

$2.54 -0.39% $-0.01 Healthcare

Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid tumors, including glioblastoma multiforme. The company is also developing PRT1419, a potent and selective inhibitor of the anti-apoptotic protein; PRT2527, a potent inhibitor of CDK9 that exhibits high kinome selectivity; PRT-SCA2, which is in preclinical stage for multiple genomically selected cancers; PRT3645, a brain penetrant molecule that potently and selectively targets CDK4/6; and PRT-K4 that is in preclinical stage for solid tumors. The company was incorporated in 2016 and is headquartered in Wilmington, Delaware.

Market cap

$139.76M

CEO

Dr. Krishna Vaddi D.V.M., Ph.D.

Full time employees

120.00

Headquarters

Wilmington, DE

IPO Date

Sep 04, 2020

Price-to-earnings (PE) Ratio

-1.44

Earnings-per-share (EPS)

$-1.77

Cash ratio (TTM)

0.94

Current ratio (TTM)

13.91

Net profit margin (TTM)

0.00%

PE ratio (TTM)

-2.02

PEG ratio (TTM)

0.02

Price-to-book ratio (TTM)

0.92

Price-to-sales ratio (TTM)

0.00

Quick ratio (TTM)

13.65

Return on assets (TTM)

-41.91%

Return on equity (TTM)

-49.75%

Similar stocks (13)

Revolution Medicines, Inc.

RVMD

$45.60 -1.26% $-0.58

Uptrend

Kymera Therapeutics, Inc.

KYMR

$49.08 0.11% $0.05

Uptrend

Nurix Therapeutics, Inc.

NRIX

$25.05 -0.04% $-0.01

Uptrend

Eliem Therapeutics, Inc.

ELYM

$8.18 -1.27% $-0.10

Uptrend

Foghorn Therapeutics Inc.

FHTX

$9.89 2.28% $0.22

Uptrend

C4 Therapeutics, Inc.

CCCC

$6.42 -2.28% $-0.15

Neutral

Monte Rosa Therapeutics, Inc.

GLUE

$6.19 -0.96% $-0.06

Neutral

PepGen Inc.

PEPG

$9.43 0.86% $0.08

Downtrend

Rezolute, Inc.

RZLT

$4.97 3.12% $0.15

Uptrend

Black Diamond Therapeutics, Inc.

BDTX

$4.74 -0.94% $-0.04

Downtrend

Shattuck Labs, Inc.

STTK

$3.73 0.78% $0.03

Downtrend

Passage Bio, Inc.

PASG

$0.69 -0.93% $-0.00

Downtrend

AN2 Therapeutics, Inc.

ANTX

$1.06 -1.85% $-0.02

Downtrend

ETF Exposure (18)

iShares Micro-Cap ETF

IWC

0.01704%

$125.65 -0.70% $-0.89

Uptrend

Vanguard Russell 2000 Value Index Fund

VTWV

0.01%

$149.00 -0.88% $-1.33

Uptrend

iShares Russell 2000 Value ETF

IWN

0.00511%

$169.18 -0.71% $-1.21

Uptrend

iShares Russell 2000 ETF

IWM

0.00262%

$222.95 -0.46% $-1.02

Uptrend

Schwab U.S. Small-Cap ETF

SCHA

0.0017599072%

$51.71 -0.48% $-0.25

Uptrend

ProShares Ultra Russell2000

UWM

9.390293086891495e-4%

$43.55 -1.22% $-0.54

Uptrend

ProShares UltraPro Russell2000

URTY

4.637738589638816e-4%

$53.30 -1.78% $-0.97

Uptrend

ProShares Hedge Replication ETF

HDG

3.9719708040937687e-4%

$50.07 0.41% $0.20

Uptrend

Dimensional U.S. Targeted Value ETF

DFAT

3.3642e-4%

$55.44 -0.84% $-0.47

Uptrend

Schwab U.S. Broad Market ETF

SCHB

1.17901e-4%

$66.00 -0.36% $-0.24

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$138.77 2.02% $2.75

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$97.80 1.74% $1.67

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$97.78 1.74% $1.67

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$137.33 1.73% $2.34

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$281.00 -0.37% $-1.04

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$137.30 1.73% $2.33

Uptrend

Vanguard Russell 2000 Index Fund

VTWO

$90.15 -0.47% $-0.43

Uptrend

Vanguard Extended Market Index Fund

VXF

$181.79 -0.62% $-1.13

Uptrend

Downtrend

Similar stocks (13)

Revolution Medicines, Inc.

RVMD

$45.60 -1.26% $-0.58

Uptrend

Kymera Therapeutics, Inc.

KYMR

$49.08 0.11% $0.05

Uptrend

Nurix Therapeutics, Inc.

NRIX

$25.05 -0.04% $-0.01

Uptrend

Eliem Therapeutics, Inc.

ELYM

$8.18 -1.27% $-0.10

Uptrend

Foghorn Therapeutics Inc.

FHTX

$9.89 2.28% $0.22

Uptrend

C4 Therapeutics, Inc.

CCCC

$6.42 -2.28% $-0.15

Neutral

Monte Rosa Therapeutics, Inc.

GLUE

$6.19 -0.96% $-0.06

Neutral

PepGen Inc.

PEPG

$9.43 0.86% $0.08

Downtrend

Rezolute, Inc.

RZLT

$4.97 3.12% $0.15

Uptrend

Black Diamond Therapeutics, Inc.

BDTX

$4.74 -0.94% $-0.04

Downtrend

Shattuck Labs, Inc.

STTK

$3.73 0.78% $0.03

Downtrend

Passage Bio, Inc.

PASG

$0.69 -0.93% $-0.00

Downtrend

AN2 Therapeutics, Inc.

ANTX

$1.06 -1.85% $-0.02

Downtrend

ETF Exposure (18)

iShares Micro-Cap ETF

IWC

0.01704%

$125.65 -0.70% $-0.89

Uptrend

Vanguard Russell 2000 Value Index Fund

VTWV

0.01%

$149.00 -0.88% $-1.33

Uptrend

iShares Russell 2000 Value ETF

IWN

0.00511%

$169.18 -0.71% $-1.21

Uptrend

iShares Russell 2000 ETF

IWM

0.00262%

$222.95 -0.46% $-1.02

Uptrend

Schwab U.S. Small-Cap ETF

SCHA

0.0017599072%

$51.71 -0.48% $-0.25

Uptrend

ProShares Ultra Russell2000

UWM

9.390293086891495e-4%

$43.55 -1.22% $-0.54

Uptrend

ProShares UltraPro Russell2000

URTY

4.637738589638816e-4%

$53.30 -1.78% $-0.97

Uptrend

ProShares Hedge Replication ETF

HDG

3.9719708040937687e-4%

$50.07 0.41% $0.20

Uptrend

Dimensional U.S. Targeted Value ETF

DFAT

3.3642e-4%

$55.44 -0.84% $-0.47

Uptrend

Schwab U.S. Broad Market ETF

SCHB

1.17901e-4%

$66.00 -0.36% $-0.24

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$138.77 2.02% $2.75

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$97.80 1.74% $1.67

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$97.78 1.74% $1.67

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$137.33 1.73% $2.34

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$281.00 -0.37% $-1.04

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$137.30 1.73% $2.33

Uptrend

Vanguard Russell 2000 Index Fund

VTWO

$90.15 -0.47% $-0.43

Uptrend

Vanguard Extended Market Index Fund

VXF

$181.79 -0.62% $-1.13

Uptrend